Key market opportunities for YUTIQ stem from the growing need for long-term management of non-infectious posterior uveitis, its advantages in sustained drug delivery, and its expanding ...

LUGANO topline data on track for mid-2026, with LUCIA readout to follow shortly after – – Continued favorable safety profile ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

Enrollment remains on track in the registrational Phase 3 trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System), with completion of ...

A new research published in the journal of Clinical Ophthalmology found that patients with a higher number of prior uveitis ...

The National Beep Baseball Association (NBBA), a national and international organization based in Glenview, IL, has the ...

A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved ...

Detailed price information for Opus Genetics Inc (IRD-Q) from The Globe and Mail including charting and trades.

As we move through 2026, the landscape of puzzle-solving has shifted dramatically from simple leisure activity to a sophisticated tool for cognitive enhancement. Recent developments in meta-puzzle ...

Older motorists could soon face new restrictions as Labour considers fresh measures in a bid to improve road safety across ...

Gene therapy for neovascular age-related macular degeneration is linked to positive anatomical changes, but variable visual outcomes.

On the 7 January 2026 the Government published its highly anticipated Road safety strategy. Five consultations were launched by the Government, including one on the introduction of mandatory eyesight ...